On March 15, 2022, the board of directors of NRx Pharmaceuticals, Inc. appointed Mr. Ira Strassberg to serve as Treasurer of the Company effective immediately. Mr. Strassberg has been serving as a financial consultant to the company since August 2021. Prior to joining the Company, Mr. Strassberg simultaneously served as Senior Managing Director and deputy CFO of Cantor Fitzgerald, L.P. from January 2018 to June 2021, and as CFO of Cantor Commercial Real Estate Company, L.P. from October 2014 to June 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.62 USD | -7.18% | +2.84% | -21.30% |
05-14 | Transcript : NRx Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
05-06 | NRx Pharmaceuticals Shares Rise 38% After Positive Drug Trial Data | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.30% | 37.73M | |
+64.92% | 62.86B | |
-1.85% | 41.38B | |
+44.76% | 40.38B | |
-8.93% | 27.64B | |
+13.05% | 26.46B | |
-21.96% | 18.9B | |
+4.21% | 12.67B | |
+25.74% | 12.27B | |
+27.42% | 12.07B |
- Stock Market
- Equities
- BRPA Stock
- News NRx Pharmaceuticals, Inc.
- NRx Pharmaceuticals, Inc. Appoints Ira Strassberg as Treasurer